Armenia’s total public debt drops by 0.9% to $4.449.6 billion in late September 2014

YEREVAN, November 4. / ARKA /. Armenia’s total public debt stood at $4.449.6 billion at the end of September 2014, dropping by 0.9% or $43.9 million from the previous month, the National Statistical Service (NSS) said.

According to official data, Armenia’s external debt fell by 1.88% or $71.6 million to $3.723.5 billion. Of that amount about $3.360.7 billion were owed by the government, a decrease of $12.4 million from the previous month of August.

Also about $451.6 million of the external debt were owed by the Central Bank of Armenia. This figure decreased $10.4 million from August.

The government’s domestic debt increased by $27.7 million to $726.1 million in late September. Of that amount about $682 million were owed by the government to resident buyers of government bonds.

The debt in foreign currency bonds amounted to $35.8 million. Also $6 million were owed as loans and $2.3 million as government guarantees. -0

spot_img

POPULAR

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Armenia’s public debt will remain stable at just above 40% in the medium term – S&P

Armenia's public debt (excluding liquid assets) will remain broadly stable at just above 40% of GDP in the medium term, according to a report from the international rating agency S&P Global Ratings.

S&P: Armenia’s banking sector is well capitalized and highly profitable

Armenia's banking sector remains well capitalized and highly profitable, supported by high net interest income and robust economic growth, according to a report from international rating agency S&P Global Ratings.

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img